Litigation Details for Genentech, Inc. v. Biogen MA Inc. (D. Mass. 2023)
✉ Email this page to a colleague
Genentech, Inc. v. Biogen MA Inc. (D. Mass. 2023)
| Docket | ⤷ Subscribe | Date Filed | 2023-07-13 |
| Court | District Court, D. Massachusetts | Date Terminated | 2023-10-23 |
| Cause | 35:271 Patent Infringement | Assigned To | Leo Theodore Sorokin |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 10,501,769; 7,332,289; 8,512,983; 9,714,293 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Genentech, Inc. v. Biogen MA Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , ⤷ Subscribe , and ⤷ Subscribe .
Details for Genentech, Inc. v. Biogen MA Inc. (D. Mass. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2023-07-13 | 1 | Complaint | 107. United States Patent No. 10,501,769 (the “’769 patent”) (Exhibit 11), was duly and legally…9,714,293; 9,902,777; 10,017,732; 10,336,983; 10,501,769; 10,662,237; 10,676,710; 10,744,201; 10,829,…vindicate their patent rights, Plaintiffs bring this Complaint seeking a judgment of patent infringement…. Plaintiffs’ claims for patent infringement arise under the patent laws of the United States, Title…product sponsor’s relevant patents in a manner that permits adjudication of patent rights before commercialization | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
